Cullinan Therapeutics (CGEM) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.8
-0.77
-0.73
-0.69

Details

Expected EPS
-0.803203
Actual EPS
-0.74
Surprise EPS
0.06
Surprise Percent
+7.87%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.74 per share for Q2 2025.

0 Comments

Share your thoughts